Pharmafile Logo

News and Press Releases

FASENRA​ approved in ​US​ for ​hypereosinophilic syndrome​

14 May 2026 -- Cambridge, UK -- AstraZeneca’s FASENRA (benralizumab) has been approved by the US FDA for the treatment of adult and pediatric patients aged 12 years and older with...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 14, 2026

Chiesi Receives MHRA Approval for Additional Dosing Regimen of Elfabrio (pegunigalsidase alfa) 2mg/kg administered every-four-weeks in adults stable with an enzyme replacement therapy

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved an additional dosing regimen of 2mg/kg administered every-four-weeks for pegunigalsidase alfa in adults stable with an enzyme replacement therapy...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 14, 2026

Chiesi
info@chiesi.uk.com
333 Styal Road Manchester M22 5LG United Kingdom

AOP Health and VRG Therapeutics Enter Co-Development Partnership for New Immunology Program

12 May 2026 -- Vienna, Austria and Budapest, Hungary -- AOP Health, a global pharmaceutical enterprise group focused on integrated therapies for rare diseases and critical care, today announced a strategic partnership...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: May 12, 2026

AOP Pharma
office@aoporphan.com
Leopold-Ungar-Platz 2 1190 Vienna, Austria

CPHI and PMEC India 2026 expands to two venues, sets a new benchmark for focused global pharma engagement

India’s largest pharmaceutical platform by Informa Markets in India is set to return for its 19th edition with a milestone expansion. Debuting a dual‑venue format in Delhi NCR, the event...

Category: Other, Pharmaceutical
Posted: May 12, 2026

CPhI & P-MEC India
India Expo cCnter, Greater Noida, Delhi NCR, India

CPHI Americas 2026 unveils keynote speakers tackling pharma’s toughest challenges

11 May 2026 -- Pennsylvania, US -- Informa Markets has announced its keynote speaker line-up for CPHI Americas 2026 (June 2–4), bringing together more than 80 industry thought leaders, including...

Category: Biotechnology, Other, Pharmaceutical
Posted: May 11, 2026

Informa
media@informa.com
5 Howick Place London SW1P 1WG UK

Building the Future of Biotechnology — UK Biotech Day 2026

15 April 2026 -- London, UK -- UK Biotech Day 2026, taking place on 27–28 May 2026, will be held at the Radisson Hotel & Conference Centre London Heathrow. The...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: April 15, 2026

UK Biotech Day
register@ukbiotechday.org
Building A, Bath Road, Heathrow Boulevard, Sipson UB7 0DU, London, UK

ELRIG Announces Inaugural US Drug Discovery Conference

Free-to-attend event takes place at Pfizer in Cambridge, MA from 16–17 June Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets....

Category: Drug Discovery, Other, Pharmaceutical
Posted: April 14, 2026

European Laboratory Research and Innovation Group (ELRIG)
info@elrig.org
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

CWOW 2026: Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

26 March 2026 -- Cambridge, UK -- Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long,interactive festival with Oxford and London for...

Category: Drug Discovery, Other, Pharmaceutical
Posted: March 26, 2026

o2h
info@o2h.com
Mill SciTech Park, Mill Lane Hauxton, Cambridge CB22 5HX

SLAS Announces the Cohort for Innovation AveNEW at SLAS Europe 2026

Twelve emerging life science startups to showcase enabling technologies at the SLAS European Conference and Exhibition in Vienna, 19-21 May 2026 23 March 2026 -- Vienna, Austria -- SLAS, the...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: March 23, 2026

Society for Laboratory Automation and Screening
slas@slas.org
1301 West 22nd Street, Suite 708 Oak Brook, IL 60523 USA

BIO-Europe Spring 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon

16 March 2026 -- Munich, Germany -- The global biopharmaceutical community is preparing to gather in Lisbon, Portugal, for the 20th edition of BIO-Europe Spring, the premier springtime partnering conference...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 16, 2026

Informa
media@informa.com
5 Howick Place London SW1P 1WG UK

MAPS Sends Expert Delegation to United Nations Commission on Narcotic Drugs

MAPS delegation includes senior researchers, policy experts, and Veterans from the US, Europe, Australia, and the Middle East The CND is a central drug policy-making body in the UN, playing...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 9, 2026

The Multidisciplinary Association for Psychedelic Studies (MAPS)
media@maps.org
3141 Stevens Creek Blvd #40563, San Jose, CA 95117

OBN Invites Life Science Leaders to Celebrate 20 Years of BioTrinity

Featuring keynotes from: Steve Bates, Executive Chair at the Office for Life Sciences, Lawrence Tallon, CEO at the MHRA & Maria Koufali, Life Sciences Industry Director at the NIHR, click...

Category: Other, Pharmaceutical
Posted: March 3, 2026

OBN
info@obn.org.uk
Unit 6 Library Avenue, Harwell, Didcot, OX11 0SG, UK

BIO-Europe Spring 2026 Charts the Future of Life Sciences from Lisbon’s Shores

25 February 2026 -- Munich, Germany -- The 20th annual BIO-Europe Spring is heading to Lisbon, Portugal, from March 23–25, 2026, with a digital experience to follow on March 31–April...

Category: Biotechnology, Drug Delivery, Other, Pharmaceutical
Posted: February 25, 2026

Informa
media@informa.com
5 Howick Place London SW1P 1WG UK

Moderna Receives MHRA Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

The LP.8.1 vaccine is the first commercially licenced mRNA vaccine to be manufactured in the UK at the Moderna Innovation and Technology Centre in Oxfordshire The updated vaccines will be...

Category: Biotechnology, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: February 10, 2026

Moderna
info@modernatx.com
Global Headquarters 200 Technology Square Cambridge, MA 02139

Data from GNT-018-IDES trial supports feasibility of imlifidase as pretreatment in gene therapy treatment for patients with Crigler–Najjar syndrome who are immune to AAV

Results presented today at ESGCT 2025 10 October 2025 -- Paris, France and Lund, Sweden -- Genethon, a worldwide pioneer and leader in research and development of gene therapy for rare...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 10, 2025

Genethon
1 bis, rue de l’Internationale 91000 EVRY-COURCOURONNES